Beclomethasone dipropionate

FDA Drug Profile — QNASL

Beclomethasone dipropionate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including QNASL. Available dosage forms: aerosol, metered, powder.

Drug details

Generic Name
Beclomethasone dipropionate
Brand Names
QNASL
Application Number
NDA202813
Sponsor
Teva Respiratory, LLC
NDC Codes
3
Dosage Forms
AEROSOL, METERED, POWDER
Routes
NASAL
Active Ingredients
BECLOMETHASONE DIPROPIONATE

Indications and Usage

1 INDICATIONS AND USAGE Beclomethasone dipropionate HFA inhalation aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Important Limitations of Use: Beclomethasone dipropionate HFA inhalation aerosol is NOT indicated for the relief of acute bronchospasm. Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for: Maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. (1) Important Limitations: Not indicated for the relief of acute bronchospasm. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.